Concepedia

K. C. Anderson

KC

Statistics

Publications

24

Citations

2K

H-Index

20

Active since

1983

Affiliations

Dana-Farber Cancer Institute(Current)

The University of Texas at Austin

Harvard University

The University of Texas at San Antonio Health Science Center

Harvard University Press

K. C. Anderson is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and pharmacology.

Publications per year

1983–2013

24

Publications

24

B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes.

Lee M. Nadler, K. C. Anderson, Gemma Pidelaserra-Martí et al. · The Journal of Immunology · 1983 · 499 citations · Full text

, , +13

Bortezomib appears to overcome the poor prognosis conferred by chromosome 13 deletion in phase 2 and 3 trials

Sundar Jagannath, Paul G. Richardson, Pieter Sonneveld et al. · Leukemia · 2006 · 265 citations

, , +16

Guidelines for blood utilization review

Linda C. Stehling, Naomi L.C. Luban, K. C. Anderson et al. · Transfusion · 1994 · 139 citations

, , +17

Deficiency of plasma plasminogen activator inhibitor 1 results in hyperfibrinolytic bleeding

M. H. Lee, K. C. Anderson, J McDonagh · Blood · 1993 · 131 citations · Full text

, , +10

Novel vitamin E analogue decreases syngeneic mouse mammary tumor burden and reduces lung metastasis.

Karla A. Lawson, K. C. Anderson, Marla Menchaca et al. · PubMed · 2003 · 90 citations

, , +13

1–5 of 24